Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation
Autor: | Ekberg, H *, Bäckman, L, Tufveson, G, Tydén, G |
---|---|
Zdroj: | In Transplantation Proceedings February-March 1999 31(1-2):267-268 |
Databáze: | ScienceDirect |
Externí odkaz: |